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Electronic cigarettes (ECs) are the most commonly used tobacco product by teens and 
young adults. The aim of this study was to determine the potential effects of EC exposure on 
cardiac health in adolescent mice. Four-week-old FVB mice were exposed to EC vapor with 20.2 
mg/mL of nicotine or vehicle alone for either 3 weeks or 3 months. Mice were exposed to HEPA-
filtered air as a control (FA). Body weight was significantly reduced in mice exposed to EC vapor 
with nicotine versus mice exposed to the EC vehicle or to the FA control. Echocardiography 
revealed that male, adolescent mice displayed reductions in fractional shortening and impaired 
diastolic function after exposure to EC with nicotine, but not in response to vehicle alone. RT-
qPCR demonstrated that EC exposure with nicotine caused an increase in left-ventricular COL1A1, 
and COL3A1 expression after 3 weeks of exposure, but this was reversed after 3 months of 
exposure. Trichrome staining showed increased vascular fibrosis following exposure to the EC 
vehicle for 3 months. Male mice exposed to EC vapor with nicotine had elevated serum 
concentrations of 3 inflammatory cytokines and 2 growth factors. While serum nicotine 
concentrations in male and female mice exposed to EC with nicotine were similar, concentrations 
of multiple metabolites were significantly lower in females. Further, the 3-
hydroxycotinine/cotinine metabolite ratio, a measure of enzymatic nicotine metabolism (CYP2A5 
activity), was significantly higher in females vs males. Further RT-qPCR targeting liver Cyp2A5 
also showed increased expression in females vs males, suggesting a more rapid rate of enzymatic 
nicotine metabolism in females. These results heighten the concern for the dangers of EC use, 
specifically in youth, and call for further work detailing the mechanistic contributions to the 
observed reduction in cardiac function. The novel results of this study demonstrate that EC vapor 





Electronic cigarettes (ECs) are the most commonly used tobacco product by middle and 
high school aged children.1 Alarmingly, a recent study found that use among this age group 
continues to increase yearly, with 9% of 8th graders, 20%, of 10th graders, and 25% of 12th graders 
having used EC products in the past month.2 With these rates in mind, there is significant concern 
as to whether exposure to hazardous inhalants found in EC vapor can cause damage during the 
sensitive window of development in school-aged children. Overall, the prolific usage of ECs has 
not been met with sufficient data to demonstrate its toxicity or relative safety to health. 
Although the field of EC research is still in its infancy, the developing body of literature 
invokes significant concern into the pulmonary and cardiovascular health effects of EC use. One 
clinical study found that EC use by adolescents is associated with increased symptoms of chronic 
bronchitis.3 Several other clinical and rodent studies have connected EC use to pulmonary 
inflammation, as evidenced by immune cell infiltration and increased inflammatory cytokines in 
bronchiolar lavage fluid.4,5 Furthermore, clinical studies have found impaired respiratory function 
and gas exchange in EC users.5,6 While the majority of EC research has been dedicated to the 
lungs, cardiovascular effects in users have also been reported. Notably, alterations in arterial 
function and integrity, and increased platelet aggregation, leading to thrombotic events, have been 
observed in rodent and human studies.7–11 Unlike these vascular findings, the cardiac effects of EC 
exposure remain largely uncharacterized. Several studies have noted that chronic EC exposure in 
adult rodents does not alter cardiac function,12,13 but investigation for more subtle abnormalities, 
especially in developing rodents, is severely lacking.  
Other sources of inhaled particulates and noxious gasses, such as traditional cigarettes and 




these inhalants has been linked to adverse cardiac outcomes characterized  
by inflammation, oxidative stress, and fibrosis.14–16 The production of many similar byproducts 
from the combustion of EC liquids raises concern into potential parallels between EC exposure 
and these established environmental triggers of disease. The composition of EC liquid includes 
nicotine, flavorings, and a vehicle of propylene glycol and vegetable glycerin, both of which have 
been deemed “generally recognized as safe” by the FDA for oral consumption, but not for 
combustion and subsequent inhalation.17 This heat combustion process is responsible for the 
formation of several presumably toxic byproducts, including reactive organic compounds, and fine 
particles (PM2.5) which have a diameter less than 2.5 μm.18,19 The small size of these particles 
allows for deep lung penetration, alveolar deposition, and entrance into pulmonary and systemic 
circulation, resulting in direct interaction with the heart.19–21 We have previously demonstrated 
that exposure to airborne PM2.5 during sensitive windows of development causes long term 
cardiac dysfunction in mice.22,23  
In this study, we sought to investigate whether an “adolescent” mouse model of EC 
exposure shows an altered cardiac phenotype. Here, we show that youth mice (1-month-old) 
exposed to EC vapor with nicotine for 3 months have significantly reduced left ventricular (LV) 
systolic and diastolic cardiac function, in males but not females, demonstrating for the first time 
an effect of vaping on cardiac function in wild type mice. These data were paired with changes in 
cardiac gene expression related to fibrosis/inflammation and sex-specific alterations in levels of 
inflammatory cytokines, growth factors, and nicotine metabolites in serum. These data call for 






Results and Discussion 
Exposures and Body Weights 
We hypothesized that the cardiovascular system may encounter significant detriment 
following EC exposure throughout the sensitive period of adolescence. We investigated this 
hypothesis utilizing a mouse model of “adolescent” EC exposure. According to prior studies, the 
adolescent period of murine development spans from post-natal day 21 to 60.24 Furthermore, it has 
previously been shown that the murine heart continues to grow and increase its output through 
postnatal week 16 (4 months).25 In this study, 3–5-week-old male (n = 24-30 per group) and female 
(n = 14-22 per group) FVB mice were exposed to EC vapor (50:50 mixture of propylene glycol 
and vegetable glycerin) with nicotine (20.2 mg/mL) or vehicle alone at relevant levels (one 70 mL 
puff per minute for 4 hrs/day, 5 days/week) for either 3 weeks or 3 months. Previously, EC users 
were shown to inhale 163±138 puffs from their EC devices each day.26 Based on these data, we 
intended to model heavy EC users with our exposure protocol (240 puffs per day) which falls 
within one standard deviation of the reported mean puffs per day. EC vapor was produced from a 
third-generation EC device attached to an exposure chamber (SCIREQ, Montreal, CA). Mice were 
exposed to HEPA-filtered air as a control (FA). Mice were exposed in batches of 3-10 mice per 
group over the course of approximately 2 years.  
Body weights were recorded at baseline and after each month of exposure. There were no 
significant differences in baseline body weight across groups (n = 15-18 per group, not shown). 
For mice with body weights recorded throughout the entire exposure period (n = 10-11 per group, 
Figure 1), body weight was significantly reduced in male mice exposed to EC vapor with nicotine 
compared to both the EC vehicle and the FA control after 1- 2- and 3-months of exposure, with no 




the EC vehicle had baseline body weights that were significantly higher than FA; however, there 
were no differences among these groups by 1 month. These data indicate that EC exposure with 
nicotine stunts weight gain during adolescent development in a sex-dependent manner.  
Vaping Reduces Left Ventricular Function in Young Male Mice 
Male mice displayed reductions in fractional shortening and E/A ratio as measured by 
ultrasound (FUJIFILM Visual Sonics, Toronto, CA) after exposure to EC vapor with nicotine for 
3 months, but not in response to vehicle alone (Figure 1). These changes were not found in mice 
exposed beginning at adulthood (3 months), female mice, mice exposed to a “casual-use” time 
frame (1 hr/day, 3 days/week), or mice exposed for only 3 weeks in duration (Supp. Figure 1). 
These results suggest that chronic e-cigarette exposure during adolescent development causes 
reduced systolic and diastolic cardiac function in a nicotine-dependent manner. Notably, these 
findings were exclusive to male adolescent mice, as adult mice unexpectedly showed a significant 
increase in fractional shortening, with no changes in diastolic function assessed via E/A ratio. 
Figure 1: Body Weights: Body weights of adolescent mice exposed to either filtered air (FA), electronic 
cigarette vapor without nicotine (EC), or electronic cigarette vapor with nicotine (EC(+Nic)). Group sizes 
range from n = 10-11 Panel A: Male and female body weights following 3 months of exposure. Panel B: 
Male body weights throughout the time course of exposure. $: EC significantly higher than FA, #: EC(+Nic) 
significantly reduced vs FA and EC. Data are expressed as mean ± SEM. *, $, #: p<.05 via two-way 
ANOVA with post-hoc Tukey’s multiple comparison test 




















































































Right ventricular function was not affected in either sex, nor was the Fulton index, suggesting no 
change in RV function or RV hypertrophy (Supp. Figure 1). Systolic and diastolic blood pressure 
was unaffected as measured by tail-cuff (Kent Scientific) 
Figure 2: Left Ventricular Echocardiography. Echocardiographic analysis of the left ventricle of male 
and female adolescent mice after 3 months of exposure to either filtered air (FA), electronic cigarette vapor 
without nicotine (EC), or electronic cigarette vapor with nicotine (EC(+Nic)). Group sizes range from n = 
24-30 for males and n = 14-22 for females. Panel A: Fractional shortening (%FS) of the left ventricle 
represents the percent change in left ventricular internal diameter from systole to diastole in parasternal 
short axis view. Panel B: E/A ratio of early (E) and late (A) diastolic transmitral flow velocities obtained 
from doppler ultrasound of mitral blood flow in apical four chamber view. Data are expressed as mean ± 
SEM. *: p<.05 via two-way ANOVA with post-hoc Tukey’s multiple comparison test. Bottom panel: 
Representative images of doppler ultrasound of mitral blood flow from FA and EC(+Nic) males. For each 
cardiac cycle, the heights of the first peak and second peaks were measured to obtain E and A wave 




























Trichrome staining of cardiac tissue in male mice revealed a distinct increase in vascular 
fibrosis in the vehicle group, relative to FA control and the nicotine group, implicating nicotine as 
a protective agent in vascular cardiac fibrosis (Figure 2). RT-qPCR performed on male LV tissue 
demonstrated that EC exposure with nicotine caused an increase in cardiac COL1A1 and COL3A1 
expression after 3 weeks of exposure; however, this was reversed after 3 months of exposure 
(Figure 2). Whether or not alterations in collagen expression and cardiac fibrosis play a role in the 
observed alterations in cardiac function will require further investigation. Regardless, these results 
indicate that EC vapor alters extracellular matrix homeostasis in mice exposed throughout 
adolescent development.  
To investigate whether changes in global cardiac function were associated with functional 
alterations at the myocyte level, cardiomyocytes were isolated after 3 months of exposure. These 
cardiomyocytes were stimulated in vitro using a Myopacer Field‐Stimulator system (IonOptix, 
Milton, MA) and functional properties of the cells were evaluated under normal conditions and 
following incubation with isoproterenol. Cardiomyocyte contractility and calcium transients were 
not affected in male or female mice, although there was a non-significant trend (p=.07 via 
ANOVA) for reduced calcium release in male, isoproterenol challenged mice exposed to EC vapor 
(Supp. Figure 2). These results indicate that the observed reductions in systolic and diastolic 
function are more likely the result of alterations in the non-myocyte components of the heart, rather 










Figure 3: Assessment of Cardiac Fibrosis. Panel A: Representative images of cardiac blood vessels from 
adolescent male mice after 3 months of exposure to either filtered air (FA), electronic cigarette vapor 
without nicotine (EC), or electronic cigarette vapor with nicotine (EC(+Nic)). Sections were subject to 
Masson’s trichrome stain and imaged under bright-field light microscope at 60x magnification. Panel B:  
Quantification of fibrosis from trichrome images, represented as percent area of blue staining region. 
Images from 5 mice per group were quantified and averaged from at least 3 images of blood vessels per 
mouse. Panel C: Relative gene expression of COL1A1 and COL3A1 in the left ventricle of adolescent male 
mice (n = 4 per group) after 3 weeks (3wk) or 3 months (3mo) of exposure measured via TaqMan-based 
real time quantitative polymerase chain reaction (RT-qPCR). Data are expressed as mean ± SEM. *: p<.05 
via one-way ANOVA with post-hoc Tukey’s multiple comparison test. All statistical analysis on RT-qPCR 
data was performed directly on ΔCT values. ΔΔCT was calculated by subtracting each sample’s ΔCT from 
the mean ΔCT from the FA control group. Relative quantity (RQ) was calculated using RQ = 2-ΔΔCT and 


















































































Vaping Increases Serum Cytokines and Growth Factors 
To examine the systemic changes manifested by EC, serum was analyzed for a panel of 42 
cytokines by immunoassay (Ampersand Biosciences, Saranac Lake, NY). Male mice exposed to 
EC vapor with nicotine had significantly elevated serum interleukin (IL)-18, chemokine C-C motif 
chemokine ligand (CCL)2, macrophage inflammatory protein (MIP)-1β, vascular endothelial 
growth factor (VEGF)-A, and stem cell factor (SCF) compared to FA (Figure 3). While several of 
these alterations were nicotine dependent, the EC vehicle was sufficient to cause some alterations, 
including MIP-1β, SCF and VEGF-A. Females had a completely different serum cytokine profile, 
as only interferon (IFN)γ was increased compared to FA and EC vehicle. Thus, EC was able to 
drive production of markers of systemic inflammation, which may cause further downstream 
changes to organ systems such as the heart.  
To investigate whether these systemic changes were associated with altered cardiac gene 
expression, RT-qPCR was performed on male mice targeting markers of inflammation and 
oxidative stress. Cardiac VCAM-1 expression followed a similar pattern to COL1A1 and COL3A1, 
showing increased expression in response to EC vapor with nicotine at 3 weeks. Following 3 
months of EC exposure, VCAM-1 expression in nicotine-exposed mice mirrored FA levels, with a 
significant decrease in the vehicle group (Figure 3). Although heterogeneity in the vehicle group 
prevented significance across groups, expression of the TNF and NOS2 appeared to be increased 
in response to EC exposure with nicotine at 3 weeks (Figure 4). By 3 months, TNF expression was 
significantly decreased in nicotine-exposed mice, and NOS2 expression returned to near-FA levels. 
VCAM-1 encodes vascular cell adhesion protein 1, a cytokine-inducible adhesion molecule that 
allows leukocytes to migrate from blood vessels into resident tissues.27 TNF and NOS2 encode the 






















Figure 4: Assessment of Systemic and Cardiac Biomarkers. Panel A: Concentration of various 
cytokines in the serum collected from male and female mice via cardiac puncture within 24 hours of 
exposure to either filtered air (FA) (n=6 male, 5 female), e-cigarette vapor without nicotine (EC) (n=3 
male, 4 female), or e-cigarette vapor with nicotine (EC(+Nic)) (n=5 male and female), A panel of 42 
cytokines/growth factors were quantified. Biomarkers with significant alterations include interleukin 18 
(IL-18), C-C motif chemokine ligand 2 (CCL2), macrophage inflammatory protein 1β (MIP-1β), vascular 
endothelial growth factor A (VEGF-A), stem cell factor (SCF), and interferon gamma (IFNγ). Panel B: 
Relative gene expression of VCAM1, TNF, and NOS2 in the left ventricle of adolescent male mice (n = 4 
per group) after 3 weeks (3wk) or 3 months (3mo) of exposure measured via TaqMan-based real time 
quantitative polymerase chain reaction (RT-qPCR). Data are expressed as mean ± SEM. *: p<.05 via one-
way ANOVA with post-hoc Tukey’s multiple comparison test. All statistical analysis on RT-qPCR data 
was performed directly on ΔCT values. 
 



























































































































inducible nitric oxide synthase 2, respectively. Taken together, these data suggest that EC vapor 
exposure with nicotine may promote both a systemic and cardiac pro-inflammatory state in male 
mice exposed throughout adolescent development. 
Female Mice Display Faster Rates of Nicotine Metabolism Than Males 
Given the many nicotine- and sex-dependent results noted in this study, we next sought to 
determine whether nicotine metabolism was different between males and females. While nicotine 
concentrations in serum of male and female mice exposed to EC with nicotine were similar, 
concentrations of metabolites including cotinine and 3-hydroxycotinine (3HC) were significantly 
lower in female mice compared to males (Figure 4). Further, the 3HC/cotinine ratio, a measure of 
cytochrome P450 2A6 (Cyp2A5 in mice) activity28, a critical enzyme in nicotine metabolism, was 
significantly and substantially increased in female mice (Figure 4). RT-qPCR of liver tissue 
targeting Cyp2A5 also showed increased expression in females as compared to males (Figure 4), 
further supporting a more rapid nicotine metabolism in female mice. Due to the fact that reductions 
in cardiac function and body weight were only observed in male mice exposed to EC vapor with 
nicotine, this finding could suggest that females exhibit some degree of protection against EC 






To our knowledge, this is the first study to evaluate cardiac function coupled with 
biomarkers of harm in young mice exposed to EC vapor. Our results heighten the concern for the 
dangers of EC use, specifically in youth, and call for further work detailing the mechanistic 
Figure 5: Nicotine Metabolism. Panel A: Concentration of nicotine and its metabolites in serum of male 
and female mice exposed for 3 months to electronic cigarette vapor with nicotine (EC(+Nic)) (n=10 per 
group) collected via submandibular bleed within 4 hours of exposure. Measurements were obtained via 
liquid chromatography-mass spectrometry (LC-MS). Measurements include nicotine, cotinine (cot), and 
3-hydroxycotinine (3HC). Panel B: Relative gene expression of CYP2A5 in the liver of adolescent male 
and female mice (n = 4 per group) after 3 months of exposure measured via TaqMan-based real time 
quantitative polymerase chain reaction (RT-qPCR). Data are expressed as mean ± SEM. *: p<.05 via 
unpaired, two-tailed student’s t-test. All statistical analysis on RT-qPCR data was performed directly on 
ΔCT values. 
 









































contributions to the observed reduction in cardiac function. While EC vapor alone was not shown 
to induce functional cardiac alterations, a synergistic effect of nicotine and its metabolites with 
reactive by-products of combustion, such as various aldehydes, could account for the observed 
effects. Regardless, the novel results of this study demonstrate that EC vapor exposure with 
nicotine can reduce cardiac function in developing male mice. 
Materials and Methods 
Animals, Exposures, and Tissue Collection 
All animals were handled according to NIH guidelines under Institutional Animal Care and 
Use Committee (IACUC) protocols approved at The Ohio State University, Columbus, Ohio. FVB 
male and female mice were housed for at least 1 week in our facility before breeding. FVB 
offspring were aged to 3-5 weeks old in our facility before the start of exposure. Following 2 days 
(1hr/day) of acclimation to the exposure chambers, adolescent mice (3-5 weeks old on day 1 of 
exposure) were exposed to EC vapor (50:50 mixture of propylene glycol and vegetable glycerin) 
with nicotine (20.2 mg/mL) or vehicle alone (one 70 mL puff per minute for 4 hrs/day, 5 
days/week) for either 3 weeks or 3 months. EC vapor was produced from a third-generation EC 
device attached to an exposure chamber (SCIREQ, Montreal, CA). Mice were exposed to HEPA-
filtered air as a control (FA). Blood pressure was recorded via tail-cuff (Kent Scientific). Body 
weight was recorded for each mouse within 1 week prior to the exposure start date and was 
recorded again after each month of exposure. Serum used for nicotine metabolism analysis was 
obtained via submandibular bleed within 4 hours of exposure. Serum used for cytokine 
immunoassay was obtained via cardiac puncture within 24 hours of exposure. Mice were 
euthanized, and heart tissue was either fixed in 4% paraformaldehyde, or divided into individual 




ratio: (RV/(LV+Septum)). Liver tissue was also collected and snap frozen in liquid nitrogen. Fixed 
tissue was transferred to 70% ethyl alcohol, paraffin embedded, and cut into 5-μm sections. 
Paraffin-embedded hearts were cut from the base to the apex. 
Echocardiography 
Echocardiographic assessments were performed using a 40‐MHz transducer (Vevo 3100; 
Visualsonics, Toronto, Ontario, Canada). Mice were anesthetized with 1% isoflurane in 100% 
O2 through a nose cone, and internal body temperature was maintained at 37°C throughout the 
assessment. Following induction of anesthesia and after the heart rate of the animal returned to 
normal (400–550 beats per minute [bpm]), parasternal short‐axis views were obtained using a 15‐
MHz probe. Cine loops collected from M mode views were analyzed for left ventricular (LV) 
systolic and diastolic internal dimensions (LVESd and LVEDd) and diameter of the pulmonary 
valve (PVd). Percent fractional shortening (%FS) was calculated using the equation: 
%FS=[(LVEDd−LVESd)/LVEDd×100]. Additionally, cine loops of blood flow velocity through 
the pulmonary valve and mitral valve were obtained via pulse wave doppler measurements from 
the parasternal short-axis view and apical four chamber view, respectively. Cine loops of 
pulmonary blood flow velocity were analyzed for a trace of the velocity time integral (VTI). Right 
ventricular (RV) stroke volume (SV) was estimated using the equation SV = [0.785 x PVd x VTI] 
and RV cardiac output (CO) was obtained by multiplying SV by heart rate. Cine loops of blood 
flow through the mitral valve were analyzed for early (E) and late (A) diastolic transmitral flow 
velocities. Transmitral E/A ratio was calculated as a ratio of the two measurements. When 
obtaining cine loops of blood flow velocity through the mitral valve, occasionally heart rate needed 
to be lowered below 400 bpm to achieve separation of the E and A waves. Data were averaged 




Masson’s Trichrome Staining 
Heart sections were stained with hematoxylin, Beibrich’s scarlet acid, and Aniline blue 
solution from Trichrome Staining Kit Assay (Abcam, Cambridge, United Kingdom) following 
instructions from the supplier. A minimum of 3 perivascular images per mouse were captured 
using bright-field light microscopy with 60X magnification. Percent fibrosis was calculated using 
ImageJ software (National Institutes of Health, Washington DC). Color images were separated via 
color deconvolution for the identification of collagen fibers. Collagen fibers were then highlighted 
by adjusting the threshold tool, and percent area was calculated using the measurement tool. Data 
from 3-5 images per mouse were averaged to obtain a single percent area value for each mouse.  
Cardiomyocyte Isolation and Measurement of Sarcomere Function and Intracellular 
Ca2+ Transients. 
Cardiomyocytes were isolated as previously described.29 Briefly, hearts were removed and 
retrogradely perfused through the aorta with Liberase and trypsin until digested. Isolated cells were 
then plated on laminin-coated glass-bottom inserts (Cell MicroControls, Norfolk, VA) for 
functional analyses. Glass-bottom inserts were perfused with warm contractile buffer within a flow 
chamber attached to an Olympus IX-71 microscope. Cells were stimulated (1 Hz, 3-ms duration) 
with a Myopacer Field-Stimulator system (IonOptix, Milton, MA), and functional properties of 
the cells were evaluated using the Sarclen Sarcomere Length Acquisition Module with a Myocam-
S Digital CCD camera video imaging system (IonOptix). Analyses of 10-15 cells from each mouse 
provided the parameters of sarcomere percent peak shortening (normalized to baseline length, 
%PS; cellular equivalent of %FS), sarcomere maximal departure, return velocities (±dl/dt), and 
sarcomere time-to-90% PS and relengthening (TPS90 and TR90, respectively). For 




for 20 min at 25°C and then washed and treated with normal culture media for 20 min at 25°C. 
Fluorescence was recorded in stimulated cardiomyocytes using a dual-excitation, single-emission 
system (IonOptix). Transients were analyzed for values of calcium release (TPS90) and reuptake 
(τ, TR90). To measure the effect of β-adrenergic stimulation on contractility and Ca2+ transients, 
cells were treated with in 10−7 M isoproterenol for 10 min prior to assessment.  
Quantitative Real-Time PCR 
Total RNA was isolated from snap frozen left ventricular heart tissue or liver tissue from 
3-week and 3-month exposed mice using the TRIzol Reagent (Invitrogen, Carlsbad, CA) following 
instructions from the supplier, and concentrations were determined using a NanoDrop 2000c 
(ThermoScientific, Wilmington, DE). 500 ng of RNA was reverse transcribed to generate cDNA 
using SuperScript IV VILO Master Mix with ezDNase Enzyme (Invitrogen, Carlsbad, CA) using 
the QuantStudio 3 Real-Time PCR System (Applied Biosystems, Foster City, CA) as a 
thermocycler. Real-time PCR was performed using the QuantStudio 3 Real-Time PCR System, 
TaqMan Fast Advanced Master Mix (Applied Biosystems, Foster City, CA), and TaqMan gene 
expression assays for mouse: COL1A1 (assay ID: Mm00801666_g1), COL3A1 (assay ID: 
Mm00802300_m1), VCAM-1 (assay ID: Mm01320969_g1), TNF (assay ID: Mm00443258_m1), 
NOS2 (assay ID: Mm00440502_m1), and CYP2A5 (Mm00487248_g1). Either 18S (assay ID: 
Mm04277571_s1) or GAPDH (assay ID: Mm99999915_g1) were used as endogenous controls. 
PCR reactions contained 4 ng cDNA (total RNA equivalent) of each sample in triplicate.  
All statistical analyses were conducted on ΔCT values. ΔΔCT was calculated by 
subtracting each sample’s ΔCT from the mean ΔCT from the FA control group. Relative quantity 





Cytokine Immunoassay Panel 
Serum samples were shipped on dry ice to undergo analysis via Mouse MAP 4.1- Sample 
Testing (Ampersand Biosciences, Saranac Lake, NY). All concentrations below the limit of 
detection were set to a concentration of 0. One male biological replicate from the vehicle group 
was excluded from all analyses due to consistently low or undetectable levels across several 
unrelated markers (e.g. insulin, interleukin-5, and VEGF-A). 
Nicotine Metabolism Assessments Using Liquid Chromatography-Mass Spectrometry 
Nicotine, nicotine-methyl-d3(Nic-d3), cotinine, and cotinine-methyl-d3(Cot-d3) were 
purchased from Sigma-Aldrich (St Louis, MO). trans-3’-Hydroxycotinine (3HC), trans-3-
Hydroxycotinine-methyl-d3 (3HC-d3), nicotine-N-glucuronide (Nic-Gluc), nicotine-methyl-d3-N-
glucuronide (Nic-Gluc-d3), cotinine-N-glucuronide (Cot-Gluc), cotinine-methyl-d3-N-
glucuronide (Cot-Gluc-d3), trans-3’-hydroxycotinine O-β-D-glucuronide (3HC-Gluc), rac trans-
3’-hydroxycotinine-d3 O-β-D-glucuronide (3HC-Gluc-d3), nicotine-N’-oxide (Nic-O), nicotine-
N’-oxide-d3 (Nic-O-D3), cotinine-N-oxide (Cot-O), cotinine-N-oxide-d3 (Cot-O-d3), rac 4-
hydroxy-4-(3-pyridyl) butanoic acid (4HPBA) dicyclohexylamine salt, and rac 4-hydroxy-4-(3-
pyridyl) butanoic-d3 acid (4HPBA-d3) dicyclohexylamine salt were purchased from Toronto 
Research Chemicals (Toronto, ON, Canada). Liquid chromatography-mass spectrometry (LC-MS) 
grade acetonitrile, ammonium formate and formic acid were purchased from Fisher Scientific (Fair 
Lawn, NJ). Ultrapure Millipore water was from the Milli-Q Ultrapure water system. 
For analysis of serum specimens, 5 µl aliquots of each specimen were spiked with 5 µl of 
an internal standard mixture that included 0.1 µg/mL of Nic-d3, Cot-d3, 3HC-d3, Nic-Gluc-d3, Cot-
Gluc-d3, 3HC-O-Gluc-d3, Nic-O-d3, Cot-O-d3, and 4HPBA-d3. After the addition of 30 µl of 




at 16,000 g for 10 min at 4°C. The supernatant was transferred into 350 µl conical glass sample 
vials for LC-MS analysis. Serum nicotine and its metabolites were detected and quantified using 
the Acquity ultra performance liquid chromatography (UPLC) system (Waters Corporation, 
Milford, MA) with a high strength silica T3 (100 X 2.1 mm, 1.8 µm) UPLC column and a Xevo 
G2-S Qtof mass spectrophotometer. The LC method was performed using a 2 µl sample injection 
volume, a 50°C column temperature and a flow rate of 0.4mL/min under the following conditions: 
a 4 min linear gradient of 98% buffer A (5 mM ammonium formate with 0.01% formic acid) to 
90% buffer A: 10% buffer B (100% acetonitrile), a subsequent gradient to 95% buffer B in 0.5 
min, followed by 1minute at 95% B. The column was re-equilibrated for one minute at initial 
conditions before the next sample injection. 
The Waters Xevo G2-S Qtof MS was operated in positive electrospray ionization MS 
sensitive mode, with capillary voltage at 0.6 kV. Nitrogen was used for both cone and desolvation 
gases at 50 L/h and 800 L/h, respectively. The source temperature was 130ºC, desolvation gas 
temperature was 500ºC. The dwell time was 0.1 sec. The cone voltage was 15 V. The mass range 
was 100-1000. The m/z traces for quantification of each compound and respective d3-labeled 
internal standards (IS) and peak retention time are: 163.12 (IS: 166.14), 2.17 minutes for nicotine; 
177.10 (IS: 180.12), 4.02 min for cotinine; 193.10 (IS: 196.12), 2.76 min for 3HC; 339.15 (IS: 
342.17), 0.63 min for Nic-Gluc; 353.14 (IS: 356.16), 0.75 min for Cot-Gluc; 369.13 (IS: 372.15), 
1.73 min for 3HC-Gluc; 179.12(IS: 182.14), 2.61 min for Nic-O; 193.10(IS: 196.12), 2.25 min for 
Cot-O; and 182.08 (IS: 185.10) 1.71 min for 4HPBA, respectively. The low quantification limit 







All data are reported as mean ± SEM. Data were graphed and analyzed using GraphPad 
Prism (Version 9; GraphPad Software Inc, San Diego, CA). Statistical analysis among groups was 
assessed using either an unpaired, two-tailed Student’s t-test or a one- or two-way ANOVA with 
post-hoc analysis vis Tukey’s multiple comparison test. The values were considered statistically 















































































































Supplemental Figure 1: Additional Measures of Global Cardiac Function. Panel A: Fractional 
Shortening (%FS) of adult mice (3 months old) exposed for 3 months to either filtered air (FA, black), 
electronic cigarette vapor without nicotine (EC, pink) or electronic cigarette vapor with nicotine (EC(+Nic), 
green) for either 4 hours per day (light) or 4 hours per day (heavy). Panel B: E/A ratio of early (E) and late 
(A) diastolic transmitral flow velocities. Panels C and D: %FS and E/A ratio in adolescent mice (1 month 
old) exposed for 3 months for 1 hour per day (Light exposure). Panel E: Cardiac output (CO) from the 
right ventricle of adolescent mice exposed for 4 hours per day for 3 months. Panel F: Fulton index (index 
of RV hypertrophy) of male and female adolescent mice exposed for 4 hours per day for 3 months. Data 




















































Supplemental Figure 2: Cardiomyocyte Function. Functional data from cardiomyocytes isolated from 
male and female adolescent mice exposed to either filtered air (FA, black), e-cigarette vapor without 
nicotine (EC, pink), or e-cigarette vapor with nicotine (EC(+Nic), green) for 3 months. Panel A: Percent 
peak shortening (%PS) of cardiomyocyte sarcomeres. Panel B: Magnitude of calcium release measured as 
a change in fluorescence ratio between 340nm and 380nm. Panels C and D: %PS and magnitude of calcium 
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